TroVax
Phase 2Completed 0 watching 0 views this week⚡ Active
47
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Colorectal Neoplasms
Conditions
Colorectal Neoplasms
Trial Timeline
Jun 1, 2004 → Dec 1, 2006
NCT ID
NCT00259844About TroVax
TroVax is a phase 2 stage product being developed by Oxford Biomedica for Colorectal Neoplasms. The current trial status is completed. This product is registered under clinical trial identifier NCT00259844. Target conditions include Colorectal Neoplasms.
Hype Score Breakdown
Clinical
17
Activity
12
Company
5
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00259844 | Phase 2 | Completed |
Competing Products
20 competing products in Colorectal Neoplasms